Importantly, siRNA-directed silencing of AR allows inhibiting the synthesis of overexpressed wild type receptors, as well as mutated or stabilized isoforms that can be encountered in advanced prostate carcinomas. This evidence concerns the gene AR and prostate carcinoma.